Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligence™ solution, featuring a new post-approval variations module. The module for post-approval variations covers regulatory changes across multiple countries, offering meticulously curated requirements to streamline tracking. With this update, pharmaceutical, biotech, and generics companies can effortlessly navigate the regulatory process and prioritize essential actions.
Dick’s Sporting Goods Lowers FY2023 Adj. EPS Guidance to $11.50 – $12.30 vs $13.50 Est, Comparable Sales Flat to +2%
Full Year 2023 Outlook (53 week year)
The Company's Full Year Outlook for 2023 is presented below and does not include any possible future charges from our business optimization that the Company has not committed
